Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant
ClinicalTrials.gov study NCT01083706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05237258. IPD Sharing: YES. Countries: 1. Publications: 0.
Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01550224. IPD Sharing: NO. Countries: 1. Publications: 0.
CPX-351 in Treating Patients With Newly Diagnosed, High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02286726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05756777. IPD Sharing: YES. Countries: 1. Publications: 0.
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
ClinicalTrials.gov study NCT07148180. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04898894. IPD Sharing: YES. Countries: 1. Publications: 0.
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
ClinicalTrials.gov study NCT00553202. IPD Sharing: Not stated. Countries: 2. Publications: 0.
AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis
ClinicalTrials.gov study NCT03718143. IPD Sharing: YES. Countries: 1. Publications: 0.
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05211570. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
ClinicalTrials.gov study NCT02121418. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02583893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02101983. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06903702. IPD Sharing: YES. Countries: 1. Publications: 0.
Study Evaluating the Safety and Efficacy of Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00037583. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior
ClinicalTrials.gov study NCT01588951. IPD Sharing: NO. Countries: 1. Publications: 0.
Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02785900. IPD Sharing: Not stated. Countries: 16. Publications: 0.
Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04848974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy
ClinicalTrials.gov study NCT00387647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation
ClinicalTrials.gov study NCT02634827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.